文献速递心血管MR

多参数心脏磁共振成像可检测心脏移植后急性心脏移植物排斥反应

Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation.
PubMed 文献 · JACC Cardiovasc Imaging · 2019-03-13

该前瞻性研究纳入58例心脏移植受者(平均年龄47.0±14.7岁)和14例对照(平均年龄47.7±16.7岁),于2014年8月至2017年5月行97次心脏磁共振检查,评估整体左心室功能及心肌T2、T1和细胞外容积分数(ECV)。结果显示,活动性≥1R级急性排斥反应患者心肌ECV较无排斥反应者显著升高(31.5±3.9% vs 26.8±3.3%,P<0.01),年龄、整体T2和整体ECV联合模型预测急性排斥反应的曲线下面积为0.84。作者认为心肌T2与ECV联合有潜力作为无创组织生物标志物,但需在急性排斥反应期间开展更大规模研究。

要点

  • 活动性≥1R级排斥反应患者ECV较无排斥反应者升高(31.5±3.9% vs 26.8±3.3%,P<0.01)。
  • 有既往排斥反应者T2较无排斥反应者升高(51.0±3.8 ms vs 49.2±4.0 ms,P=0.02)。
  • 年龄、整体T2和整体ECV联合模型预测排斥反应的AUC为0.84。

核心结论

  • 心脏磁共振衍生的心肌T2与ECV联合有潜力作为急性心脏移植物排斥反应的无创组织生物标志物。

研究设计与样本

  • 前瞻性研究,纳入58例心脏移植受者(平均年龄47.0±14.7岁)和14例对照(平均年龄47.7±16.7岁),2014年8月至2017年5月行97次心脏磁共振检查,以活检分级为参考标准。

关键影像表现/征象

  • 有既往排斥反应者心肌T2高于无排斥反应者(51.0±3.8 ms vs 49.2±4.0 ms,P=0.02)。
  • 无排斥反应者心肌T2高于对照(49.2±4.0 ms vs 45.2±2.3 ms,P<0.01)。
  • 活动性≥1R级排斥反应者T2高于无排斥反应组(52.4±4.7 ms vs 49.2±4.0 ms,P<0.01),但与既往排斥反应组无显著差异。
  • 活动性≥1R级排斥反应者ECV高于无排斥反应者(31.5±3.9% vs 26.8±3.3%,P<0.01)。
  • 活动性≥1R级排斥反应者ECV高于有既往排斥反应者(31.5±3.9% vs 26.8±4.0%,P<0.01)。

诊断标准与关键数值

  • 年龄、整体T2和整体ECV联合模型预测急性排斥反应的AUC为0.84。

临床应用与阅片要点

  • 心肌T2与ECV联合有潜力作为急性心脏移植物排斥反应的无创组织生物标志物。
  • 需在急性排斥反应期间开展更大规模研究以继续开发多参数心脏磁共振用于移植受者监测。

局限性

  • 需在急性排斥反应期间开展更大规模研究以继续开发多参数心脏磁共振用于移植受者监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The purpose of this study was to evaluate the sensitivity of multiparametric cardiac magnetic resonance imaging (CMR) for the detection of acute cardiac allograft rejection (ACAR).

BACKGROUND: ACAR is currently diagnosed by endomyocardial biopsy, but CMR may be a noninvasive alternative because of its capacity for regional myocardial structure and function characterization.

METHODS: Fifty-eight transplant recipients (mean age 47.0 ± 14.7 years) and 14 control subjects (mean age 47.7 ± 16.7 years) were prospectively recruited from August 2014 to May 2017 and underwent 97 CMR studies (83 transplant recipients, 14 control subjects) for assessment of global left ventricular function and myocardial T2, T1, and extracellular volume fraction (ECV). CMR studies were divided into 4 groups on the basis of biopsy grade: control subjects (n = 14), patients with no ACAR (no history of ACAR; n = 36), patients with past ACAR (history of ACAR; n = 24), and ACAR+ patients (active grade ≥1R ACAR; n = 23).

RESULTS: Myocardial T2 was significantly higher in patients with past ACAR compared with those with no ACAR (51.0 ± 3.8 ms vs. 49.2 ± 4.0 ms; p = 0.02) and in patients with no ACAR compared with control subjects (49.2 ± 4.0 ms vs. 45.2 ± 2.3 ms; p < 0.01). ACAR+ patients demonstrated increased T2 compared with the no ACAR group (52.4 ± 4.7 ms vs. 49.2 ± 4.0 ms, p < 0.01) but not compared with the past ACAR group. In contrast, ECV was significantly elevated in ACAR+ patients compared with transplant recipients without ACAR regardless of history of ACAR (no ACAR: 31.5 ± 3.9% vs. 26.8 ± 3.3% [p < 0.01]; past ACAR: 31.5 ± 3.9% vs. 26.8 ± 4.0% [p < 0.01]). Receiver operating characteristic curve analysis revealed that a combined model of age at CMR, global T2, and global ECV was predictive of ACAR (area under the curve = 0.84).

CONCLUSIONS: The combination of CMR-derived myocardial T2 and ECV has potential as a noninvasive tissue biomarker for ACAR. Larger studies during acute ACAR are needed for continued development of multiparametric CMR for transplant recipient surveillance.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Dolan RS, Rahsepar AA, Blaisdell J, et al. Multiparametric Cardiac Magnetic Resonance Imaging Can Detect Acute Cardiac Allograft Rejection After Heart Transplantation. JACC Cardiovasc Imaging. 2019. PMID: 30878427. doi:10.1016/j.jcmg.2019.01.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。